Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer

Leila Pourali; Ali Taghizadeh kermani; Mohammad Reza Ghavamnasiri; Fahimeh Khoshroo; Sare Hosseini; Mehdi  Asadi; Kazem Anvari

International Journal of Cancer Management

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

Outlines

Abstract
Copyright

Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer

Author(s):

Leila Pourali¹,

Ali Taghizadeh kermani^2,*,

Mohammad Reza Ghavamnasiri³,

Fahimeh Khoshroo³,

Sare Hosseini³,

Mehdi Asadi⁴,

Kazem Anvari³

1Women's Health Research Center, Ghaem Hospital, Faculty of Medicine , Mashhad University of Medical Sciences, Mashhad, Iran

2Surgical Oncology Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Cancer Research Center, Omid Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3Cancer Research Center, Omid Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4Surgical Oncology Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

International Journal of Cancer Management:Vol. 6, issue 3; e80423

Published online:Sep 30, 2013

Article type:Research Article

Received:Jun 18, 2013

Accepted:Jul 17, 2013

How to Cite:Leila PouraliAli Taghizadeh kermaniMohammad Reza GhavamnasiriFahimeh KhoshrooSare HosseiniMehdi AsadiKazem Anvariet al.Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer.Int J Cancer Manag.6(3):e80423.

Abstract

Background: Chemotherapy-induced amenorrhea is one of long term side effects of adjuvant chemotherapy in patients with breast cancer which may interfere with their future reproductive function. Although amenorrhea is well recognized, the actual incidence following taxanes remains uncertain.

Methods: In a cross sectional study, we identified breast cancer patients aged 45 years or younger who were treated with adjuvant anthracycline and taxanebased regimens at three different oncology departments from 2001-2008.

Results: One hundred and nineteen patients met all eligibility criteria and consented to participate in a regular follow up program. The median age at diagnosis was 33.5 years (range, 25-41). Seventy (58%) patients developed amenorrhea for at least 12 months following completion of treatment, and regular menses were maintained in another 49 (42%) patients. No statistically significant association was found between age and development of amenorrhea, although those who experienced cessation of menses were older.

Conclusion: Although taxane containing chemotherapy was associated with higher rate of amenorrhea compared to FAC, this was not statistically significant (P=0.11). Also, treatment with tamoxifen and Estrogen Receptor (ER) positive status was significantly correlated with chemotherapy induced amenorrhea.

Keywords

Fulltext

The Full text is available in PDF.

comments